Dexamethasone Treatment of Congenital Adrenal Hyperplasia

Summary

The purpose of this study is to determine if dexamethasone given at night is a more effective treatment for congenital adrenal hyperplasia in young children than standard three times per day hydrocortisone. Our hypothesis is that nocturnal dexamethasone will lead to more efficient suppression of the hypothalamic-pituitary-adrenal axis. We performed a cross-over trial comparing hormonal control during two 24-hour hospitalizations, one on hydrocortisone and one on nocturnal dexamethasone.

Timeline

Start

2008-04

Primary completion

2009-06

Completion

2009-06

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Dexamethasone Admission vs Hydrocortisone Admission; p = 0.09; Percent Difference -19; t-test, 2 sided NCT00621985 ↗

Publications

• Results Dauber A, Feldman HA, Majzoub JA. Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia. Int J Pediatr Endocrinol. 2010;2010:347636. doi: 10.1155/2010/347636. Epub 2010 Sep 14.

Drugs

Indications